There is no insurance approved treatment for lp(a), but there are drugs that have been proven to dramatically lower lp(a). The next step, that is ongoing, are studies that show lowering lp(a) lowers MACE. There's a study that is expected to conclude this year. Then FDA approval. Then insurance coverage. The studies I looked at for impact on MACE required 175 nmol/L or greater. So there's also the issue of who would qualify if/when it makes it to insurance coverage. Best case, a few years out? At least this is my uneducated understanding of the process.